Publication

Video

Supplements and Featured Publications
Novel Emerging Therapies in Relapsed/Refractory AML
Volume 1
Issue 1

Dr. Becker on the Rationale for Investigating Uproleselan in Combination with Chemotherapy in AML

Pamela S. Becker, MD, PhD, discusses the rationale for investigating uproleselan in combination with chemotherapy in relapsed/refractory acute myeloid leukemia.

Pamela S. Becker, MD, PhD, Department of Hematologic Malignancies, City of Hope, discusses the rationale for investigating uproleselan (GMI-1271) in combination with chemotherapy in relapsed/refractory acute myeloid leukemia (AML).

Preclinical studies of uproleselan done in Australia by a group led by investigator Ingrid Winkler showed that AML cells in mice enhanced proinflammatory mediators, which increased E-selectin expression in the bone marrow microenvironment, Becker says. Additionally, this research demonstrated mediators expressed by AML could not up-regulate the E-selectin, due to prevention from the TNFα blockade , Becker explains.

Moreover, preclinical work with uproleselan generated a decrease to the pro-survival pathways that are active in the AML, Becker continues. This process sensitized the AML cells to chemotherapy, Becker continues. Mouse models elicited an improved survival of mice if they were treated with chemotherapy plus the uproleselan, vs chemotherapy alone, Becker concludes.

Related Videos
Jonathan Spicer, MD, PhD, FRCS
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center